Rubedo Life Sciences

Treating age-related diseases to extend health-span

[Akshay Pujari @el_akshay]

Sharing the latest from @NatureNeuro journal:
Our computational work at @LifeRubedo in collaboration with leading scientists from @StanfordMed is featured on the cover.

Grateful for the opportunity to contribute to such impactful work in a small capacity.
https://t.co/QMCSzQYOOU

[Rubedo Life Sciences @LifeRubedo]

We’re excited to announce a major milestone at Rubedo Life Sciences: our first patients have been dosed!

With this, Rubedo officially enters the clinic as a clinical-stage longevity biotech.

https://t.co/pY1Q5Okrsm

[Rubedo Life Sciences @LifeRubedo]

breakthrough discovery: featured on the cover, our new paper on Nature Neuroscience with Prof. Tawfik lab at Stanford University, showing first-in-class senescence sensory neurons to treat neuropathic pain
https://t.co/0rPDVm8gKe

[Rubedo Life Sciences @LifeRubedo]

We are excited to announced a strategic partnership with @Beiersdorf_AG to advance the skincare industry with a disruptive and innovative product, born from deep science of aging and cellular senescence biology https://t.co/NZ4lvZQO0U

[Rubedo Life Sciences @LifeRubedo]

We are stocked to announced that we closed our $40M+ Series A led by @khoslaventures and Ahren Innovation capital to advance the company to the clinic with our first program, entry point to broader therapeutic areas of chronic diseases of aging https://t.co/usnEU4x0yA

[IAG @italianangels]

💣New investment for IAG #businessangels: @LifeRubedo

👩‍🔬 #biopharmaceuticals Rubedo Life Sciences secures a substantial $40M Series A financing round, with a focus on advancing groundbreaking therapies targeting age-related diseases.

https://t.co/jmPM13VCQj

[C&EN (Chemical & Engineering News) @cenmag]

.@LifeRubedo just brought in $40 million in a series A financing round co-led by @khoslaventures and Ahren Innovation Capital. The start-up will develop medicines for aging cells that drive skin and fibrotic diseases: https://t.co/82Omi8Gd3j

[Longevity Technology @LongevityTech]

Rubedo lands $40m to advance senescence-targeting therapeutics into clinical trials...
Longevity biotech @LifeRubedo plans Phase 1 #senotherapeutics trial this year as it seeks to keep people ‘biologically young.’
#longevity #investment #senescence

https://t.co/dp07wVlvUV

[Rubedo Life Sciences @LifeRubedo]

Celebrating with @khoslaventures team and Rubedo team our Series A and the partnering deal with @Beiersdorf_AG

[Rubedo Life Sciences @LifeRubedo]

@tweeter celebrating our $40M+ Series A led by @khoslaventures and Ahren Innovation Capital to advance Rubedo to the clinic with our first program, entry point to larger therapeutic areas of chronic diseases of aging https://t.co/usnEU4x0yA

[Rubedo Life Sciences @LifeRubedo]

@tweeter announcing our partnership with @Beiersdorf_AG to disrupt and innovate together the skincare industry with the first real rejuvenative product, born from @StanfordMed and @Rubedolife deep science of cellular senescence and aging biology https://t.co/NZ4lvZQO0U

[Phaedon Institute @PhaedonInstitut]

We are excited to share the report of the Seno-Therapeutics Summit 2023.

You can read the paper now published on Nature Portfolio journal npj #aging by Summit chairs Dr. Marco Quarta, our President, and Dr. Marco Demaria, our Chairman of the SAB.

https://t.co/xh293XHOSz

[Buck Institute @BuckInstitute]

@PhaedonInstitut is hosting a Senotherapeutics Summit at Buck on Nov 7-8. Fantastic line up of speakers and panelists all focused on #senescence.
Register here: https://t.co/agkiU4q0K9
#phaedoninstitute #senotherapeuticsummit2023 #longevity

[Phaedon Institute @PhaedonInstitut]

"There are no competitors in senotherapeutics – we are all collaborators."
Great article by @LongevityTech discussing the upcoming #SenoTherapeuticsSummit with our President @MarcoQuarta12!

[Rubedo Life Sciences @LifeRubedo]

https://t.co/0La5JxRObn

[Rubedo Life Sciences @LifeRubedo]

The RIse of Longevity Therapeutics - nice article on Pharma Exec by Dr. @Marco4Quarta12 CEO & CoFounder of Rubedo https://t.co/tf5ELIS7Is

[Rubedo Life Sciences @LifeRubedo]

great article on @LifeRubedo by @LongevityTech
https://t.co/N2nejKQyLp

[BioAge @bioagelabs]

TODAY: @bioagelabs CEO @kpfortney joins a Clubhouse Q&A about the @beOnDeck Longevity Biotech Fellowship. ODLB brings people together to build, join, and invest in revolutionary longevity biotechnology startups!

Monday, July 12, 10:30 AM PDT
https://t.co/5eSnRq4Rm2

[Rubedo Life Sciences @LifeRubedo]

Be sure to check out the latest @PrimeMoversLab webinar on Wednesday at 12:00 PT/3:00 ET exploring the technologies that are helping us live longer and the startups making the biggest breakthroughs.

Register here: https://t.co/gvsWiTAc3f